Alan Robert Saltiel

Ann Arbor, MI, United States of America

Alan Robert Saltiel

This inventor holds 23 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 3 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Warner-Lambert Company, University of Michigan, The Rockefeller University. Active years: 1989-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alan Robert Saltiel. Retrieved from https://idiyas.com/inventor/alan-robert-saltiel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 23 

% Patents Active = 65.2


 

Average Co-Inventor Count = 3.1

ph-index = 11

Forward Citations = 482(Granted Patents)


Location History:

  • Irvington, NY (US) (1989)
  • New York, NY (US) (1990)
  • Ann Arbor, MI (US) (1996 - 2020)

Company Filing History:


Years Active: 1989-2020

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Amlexanox
MEK Inhibitors
Obesity Treatments
Insulin Activity
Carboxyalkylethers
Septic Shock
Vascular Diseases
Protein Targeting
23 patents (USPTO):Explore Patents

Title: Alan Robert Saltiel - Innovator from Ann Arbor

Introduction: Alan Robert Saltiel is a renowned inventor based in Ann Arbor, Michigan. His groundbreaking work in the field of biotechnology and genetics has earned him international recognition.

Latest Patents: Alan Robert Saltiel holds several patents related to novel gene editing techniques and therapeutic interventions for metabolic disorders. His most recent patent focuses on a revolutionary method for targeting specific genes associated with diabetes.

Career Highlights: With a distinguished career spanning over three decades, Saltiel has held key research positions at prestigious institutions such as the University of Michigan and the Howard Hughes Medical Institute. He has published numerous research papers that have significantly advanced our understanding of metabolic diseases.

Collaborations: Saltiel has collaborated with leading pharmaceutical companies and research institutions worldwide to develop innovative treatments for diabetes, obesity, and other metabolic conditions. His collaborative efforts have resulted in the development of cutting-edge therapies that are currently in clinical trials.

Conclusion: Alan Robert Saltiel's relentless pursuit of scientific excellence and his passion for improving human health have cemented his reputation as a pioneering inventor in the field of biotechnology. His innovative contributions continue to inspire the next generation of researchers and innovators.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…